High dose of an n-3 polyunsaturated fatty acid diet lowers activity of C57BL/6 mice

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 86, Issue 3, 2012, Pages 137-140

  Drew Rockett, Benjamin ^a   Harris, Mitchel ^a   Raza Shaikh, Saame ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Body weight; Fish oil; Flaxseed oil

Indexed keywords

LINSEED OIL; OMEGA 3 FATTY ACID;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CARBON DIOXIDE TENSION; CONTROLLED STUDY; ENERGY EXPENDITURE; FAT INTAKE; FOOD INTAKE; LIPID DIET; LOCOMOTION; LUNG GAS EXCHANGE; MALE; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; REARING; RUNNING; WALKING;

ANIMALS; DIETARY FATS, UNSATURATED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENERGY METABOLISM; FATTY ACIDS, OMEGA-3; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY;

MUS;

EID: 84858438984     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2011.12.001     Document Type: Article

References (20)

1. Fetterman J.W., Zdanowicz M.M. Therapeutic potential of n-3 polyunsaturated fatty acids in disease. Am. J. Health Syst. Pharm. 2009, 66:1169-1179.
2. Fedor D., Kelley D.S. Prevention of insulin resistance by n-3 polyunsaturated fatty acids. Curr. Opin. Clin. Nutr. Metab. Care 2009, 12:138-146.
3. Galli C., Calder P.C. Effects of fat and fatty acid intake on inflammatory and immune responses: a critical review. Ann. Nutr. Metab. 2009, 55:123-139.
4. Davidson M.H., Stein E.A., Bays H.E., et al. Efficacy and tolerability of adding prescription omega-3 fatty acids 4g/d to simvastatin 40mg/d in hyper triglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study. Clin. Ther. 2007, 29:1354-1367.
5. Hoy S.M., Keating.G.M. Omega-3 ethylester concentrate: a review of its use in secondary prevention post-myocardial infarction and the treatment of hyper triglyceridaemia. Drugs 2009, 69:1077-1105.
6. Kim W., McMurray D.N., Chapkin R.S. n-3 polyunsaturated fatty acids-physiological relevance of dose. Prostaglandins Leukot. Essent. Fatty Acids. 2010, 82:155-158.
7. Bang H.O., Dyerberg J., Sinclair.H.M. The composition of the eskimo food in north western Greenland. Am. J. Clin. Nutr. 1980, 33:2657-2661.
8. Dyerberg J., Bang H.O., Hjorne N. Fatty acid composition of the plasma lipids in Greenland eskimos. Am. J. Clin. Nutr. 1975, 28:958-966.
9. Cunnane S.C., Ganguli S., Menard C., et al. High alpha-linolenic acid flaxseed (Linum usitatissimum): some nutritional properties in humans. British J. Nutr. 1993, 69:443-453.
10. Burns C.P., Halabi S., Clamon G., et al. Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia. Cancer 2004, 101:370-378.
11. Kremer J.M., Lawrence D.A., Petrillo G.F., et al. Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal anti-inflammatory drugs. Clinical and immune correlates. Arthritis Rheum. 1995, 38:1107-1114.
12. Rockett B.D., Salameh M., Carraway K., et al. n-3 PUFA improves fatty acid composition, prevents palmitate-induced apoptosis, and differentially modifies B cell cytokine secretion in vitro and ex vivo. J. Lipid Res. 2010, 51:1284-1297.
13. Rockett B.D., Franklin A., Harris M., et al. Membrane raft organization is more sensitive to disruption by (n-3) PUFA than nonraft organization in EL4 and B cells. J. Nutr. 2011, 141:1041-1048.
14. Kim J.-Y., van de Wall E., Laplante M., et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J. Clin. Invest 2007, 117:2621-2637.
15. Barber M.D., McMillan D.C., Preston T., et al. Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement. Clin. Sci. 2000, 98:389-399.
16. Bortolotti M., Tappy L., Schneiter P. Fish oil supplementation does not alter energy efficiency in healthy males. Clin. Nutr. 2007, 26:225-230.
17. Jones P.J.H., Jew S., AbuMweis S The effect of dietary oleic, linoleic, and linolenic acids on fat oxidation and energy expenditure in healthy men. Metab. Clin. Exp. 2008, 57:1198-1203.
18. Macallan D.C., Noble C., Baldwin C., et al. Energy expenditure and wasting in human immunodeficiency virus infection. N. Engl. J. Med. 1995, 333:83-88.
19. Kosmiski L.A., Kuritzkes D.R., Lichtenstein K.A., et al. Fat distribution and metabolic changes are strongly correlated and energy expenditure is increased in the HIV lipodystrophy syndrome. AIDS 2001, 15:1993-2000.
20. Grinspoon S., Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N. Engl. J. Med. 2005, 352:48-62.